Veatriki Athanasiou

Ophthalmology occupies a unique position at the intersection of medicine and surgery, requiring both precise anatomical assessment and a broad understanding of systemic disease. During my Foundation Year 2 taster week at Moorfields Eye Hospital, I was exposed to a wide spectrum of ophthalmic practice across Eye Casualty, medical retina, glaucoma, corneal, adnexal, and ocular oncology clinics. This experience highlighted how meticulous ocular examination can provide important insights into wider systemic pathology. Among the cases encountered, anterior uveitis emerged as a particularly instructive condition, serving as a framework through which the relationship between ocular inflammation and systemic disease could be explored.

In Eye Casualty, presentations ranged from benign, self-limiting conditions such as conjunctivitis to sight-threatening emergencies including microbial keratitis and acute angle-closure glaucoma. Early in the week, I observed clinicians conducting structured slit-lamp examinations, paying close attention to patterns of conjunctival injection, corneal clarity, and evidence of anterior chamber inflammation. Under supervision, I was able to practise slit-lamp examination myself, initially finding it challenging to coordinate magnification, illumination, and patient positioning simultaneously. With repeated exposure and targeted feedback, I became more confident in adjusting beam height and width to assess corneal fluorescein staining, identify anterior chamber cells and flare, and evaluate pupillary responses. Although I did not make independent diagnoses, I learned to construct structured differential diagnoses and to recognise features warranting urgent senior review, reinforcing the importance of a systematic approach to the red eye.

Attendance at medical retina and glaucoma clinics provided insight into the longitudinal nature of ophthalmic disease management. In contrast to the acute presentations seen in Eye Casualty, these clinics demonstrated how diagnostic and therapeutic decisions evolve over time. Observing the use of multimodal retinal imaging illustrated how objective data guide long-term management, while the glaucoma service highlighted the challenge of balancing disease control with treatment burden in chronic, often asymptomatic disease. Time spent in corneal and adnexal theatres emphasised the precision required in ophthalmic microsurgery and the importance of meticulous pre-operative assessment. However, it was within anterior segment clinics that I found the greatest intellectual engagement. Repeated exposure to patients with uveitis required integration of slit-lamp findings with systemic history, prompting consideration of pathology beyond the eye itself.

During these clinics, I became increasingly aware of how frequently uveitis presents without an immediately identifiable underlying cause and how unsettling this uncertainty can be for patients. Many expressed concern that ocular inflammation might reflect a serious systemic condition. I observed how clinicians balanced reassurance with vigilance, emphasising the importance of careful history-taking, targeted investigation, and appropriate follow-up despite diagnostic uncertainty.

One patient presented with a painful, photophobic unilateral red eye of several days’ duration, representing their second similar episode. Ocular history revealed previous improvement with topical corticosteroids, while the medical history included intermittent lower back pain managed conservatively, without a formal rheumatological diagnosis. The patient expressed frustration with the relapsing nature of the condition and concern regarding the long-term effects of repeated steroid use. During the consultation, the clinician revisited systemic symptoms, explained the rationale for further investigations, and discussed prognosis without assigning premature diagnostic labels. Observing this interaction highlighted the importance of validating patient anxiety while maintaining a structured, evidence-based approach to care.

Across clinics, differences emerged between the experiences of patients with acute and recurrent uveitis. Patients presenting acutely were often distressed by pain and photophobia and focused primarily on rapid symptom relief. In contrast, those with recurrent disease described frustration with frequent follow-up appointments, prolonged topical treatment regimens, and anxiety about complications such as cataract formation or secondary glaucoma. A particular challenge observed early in treatment was adherence to intensive topical steroid regimens, including hourly dexamethasone drops, sometimes required overnight. Several patients, particularly older individuals, found these regimens physically exhausting and disruptive to daily life, raising concerns about missed doses and treatment efficacy. Clinicians addressed these concerns by clearly explaining the rationale for aggressive early inflammation control, discussing realistic adherence strategies, and reassuring patients that treatment intensity would be reduced as inflammation resolved.

These observations reinforced that effective management of uveitis extends beyond prescribing medication and requires careful communication and expectation-setting. Acknowledging treatment burden, assessing a patient’s capacity to adhere to intensive regimens, and arranging timely senior review when response is suboptimal are integral components of care.

Exposure to discussions around steroid-sparing therapies provided insight into how advances in immunology are shaping contemporary uveitis management. Understanding the immunological pathways underpinning these treatments, including the roles of the IL-23/Th17 axis and the JAK-STAT pathway in sustaining inflammatory responses, clarified why certain patients benefit from targeted immunomodulatory therapy rather than repeated courses of corticosteroids. While prescribing biologic agents lies outside the remit of a foundation doctor, this knowledge enhanced my ability to recognise steroid dependency, monitor for treatment-related complications, and escalate care appropriately within specialist-led pathways. It also supported more informed communication with patients regarding long-term disease control and multidisciplinary management. This taster week reinforced the intellectual breadth of ophthalmology and its close integration with systemic medicine. In patients presenting with suspected uveitis, I learned the importance of a structured presenting complaint, detailed ocular assessment, and a comprehensive medical history extending beyond ophthalmology. Uveitis exemplifies how a localised ocular presentation may serve as a window into systemic disease. For foundation doctors, recognising red-flag features and understanding when to escalate care are essential for preserving vision and facilitating timely systemic diagnosis.